APA (7th ed.) Citation

Lee, S. S., Sherman, M., Ramji, A., Greenbloom, S., Elkashab, M., Pluta, H., . . . Myers, R. P. (2012). Randomised clinical trial: The efficacy of treatment, guided by a shorter duration of response, using peginterferon alfa-2a plus ribavirin for hepatitis C virus other than genotypes 2 or 3. Alimentary Pharmacology & Therapeutics, 35(1), 37. https://doi.org/10.1111/j.1365-2036.2011.04911.x

Chicago Style (17th ed.) Citation

Lee, S. S., et al. "Randomised Clinical Trial: The Efficacy of Treatment, Guided by a Shorter Duration of Response, Using Peginterferon Alfa-2a Plus Ribavirin for Hepatitis C Virus Other than Genotypes 2 or 3." Alimentary Pharmacology & Therapeutics 35, no. 1 (2012): 37. https://doi.org/10.1111/j.1365-2036.2011.04911.x.

MLA (9th ed.) Citation

Lee, S. S., et al. "Randomised Clinical Trial: The Efficacy of Treatment, Guided by a Shorter Duration of Response, Using Peginterferon Alfa-2a Plus Ribavirin for Hepatitis C Virus Other than Genotypes 2 or 3." Alimentary Pharmacology & Therapeutics, vol. 35, no. 1, 2012, p. 37, https://doi.org/10.1111/j.1365-2036.2011.04911.x.